500 breast cancer survivors to be tracked for years to uncover Long-Term health secrets

NCT ID NCT04661982

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study follows 500 breast cancer survivors (stage 0-IIIC) who were treated at City of Hope. Researchers will collect feedback and samples over time to understand long-term health, quality of life, and how the immune system responds to cancer. The goal is to improve follow-up care for future survivors.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this study could help define better long-term care guidelines for breast cancer survivors and improve understanding of how the immune system fights cancer.
What could go wrong
This is an observational study, not a treatment trial. It will not directly test any new therapy, and results may take years to influence clinical practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • City of Hope Medical Center

    Duarte, California, 91010, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.